Welcome to Research
We aim to develop innovative pharmacotherapeutic treatment strategies and drug development strategies across the full drug life-cycle, from a societal perspective.
See some of the most important goals for this research program.
Nielka van Erp's research group focuses on describing, explaining, understanding and modifying the pharmacokinetics of oral anticancer drugs.
Saskia de Wildt's research group studies drug behavior in groups of children and pregnant individuals who receive off-label prescriptions and translate those findings into safer dosing guidelines using pharmacokinetic modeling and AI.
Elke de Jong's research group aims at improving care, treatment, translational research, implementation and eduction regarding patients with inflammatory skin diseases.
dr. Rob ter Heine